# Mike Stapleton

> Mike Stapleton is the Chief Business Officer of QbDVision, the Austin-based software company building a Digital CMC platform for pharma and biotech. He spent three decades moving between the lab bench, the boardroom, and the consulting deck - senior scientist at BP, COO at Accelrys, leader at Life Technologies, PerkinElmer, Merck, Microsoft, and Accenture - before joining QbDVision's board and then stepping in to run its commercial strategy. His argument is contrarian for a software executive: the bottleneck in drug development is not the platform, it is the people willing to standardize how an industry handles its data.

- **Role:** Chief Business Officer at QbDVision
- **Organizations:** QbDVision, Rady Children's Hospital-San Diego, Northpond Ventures, Scitara Corporation, Culture Biosciences
- **Nationality:** Irish
- **Education:** Bachelor of Engineering (Honours), University College Dublin, Diploma, Dublin Business School, Master of Science, Michael Smurfit Graduate School of Business (University College Dublin)
- **Known for:** Helped grow Accelrys from a startup into a global operation as EVP & COO, Built and led PerkinElmer's scientific software business as General Manager, Led the first life sciences eBusiness transformation at Life Technologies

## Career timeline

- **Early career** — Began as a Senior Scientist at BP
- **—** — Executive Vice President & Chief Operating Officer at Accelrys, helping grow it from a startup to a global operation
- **—** — Vice President, Informatics, Marketing & Ebusiness at Life Technologies, delivering the first life sciences eBusiness transformation
- **—** — General Manager at PerkinElmer, where he built and led the scientific software business
- **—** — Vice President & CIO of R&D IT at Merck, deploying cloud-based data and analytics offerings
- **—** — Global Operational Excellence Leader at Microsoft, overseeing contract, cloud cost, subscription and billing optimization
- **—** — Managing Director, Life Sciences at Accenture, building and running its North America Life Sciences innovation practice
- **2024** — Joined the QbDVision board of directors after a period as a company advisor
- **2025-04** — Stepped into an operating role as Chief Business Officer at QbDVision

## Achievements

- Helped grow Accelrys from a startup into a global operation as EVP & COO
- Built and led PerkinElmer's scientific software business as General Manager
- Led the first life sciences eBusiness transformation at Life Technologies
- Deployed novel cloud-based data and analytics offerings at Merck as VP & CIO of R&D IT
- Built and managed Accenture's North America Life Sciences innovation practice
- Advises the board of the Rady Children's Institute for Genomic Medicine and serves on its Board Data Analytics Task Force
- Launched Project Artemis and the Digital CMC Consortium at QbDVision
- Joined QbDVision as CBO as the company closed $13M, bringing Series A funding to $28M

## Latest updates

- **2025-04** — Named Chief Business Officer of QbDVision, moving from the board into an operating leadership role.
- **2025-05** — QbDVision closed $13M in new financing co-led by Northpond Ventures and S3 Ventures, bringing its Series A to $28M with Stapleton leading commercial strategy.

## Links

- Website: https://qbdvision.com
- LinkedIn: https://www.linkedin.com/in/michaelrstapleton/
- Twitter/X: https://twitter.com/qbdvision

---

Profile page: https://yespress.io/mike-stapleton
Published by YesPress — https://yespress.io
Last updated: 2026-06-10